Reckitt’s Mead Johnson has been approved by the United States Food and Drug Administration to provide enough infant formula powder to make 6 million servings.
The company said it would import 331,000 pounds of powder from its nutrition facility in Delicias, Mexico.
“When mixed and packaged, in the United States, it will yield the equivalent of 6 million 8oz servings of PurAmino, Mead Johnson’s amino acid-based formula. This first shipment of PurAmino will be produced in August and is expected to be distributed immediately after the completion of Reckitt’s rigorous quality and safety checks in the United States.
Reckitt said the PurAmino specialty formula is designed to feed babies and toddlers “who cannot digest other types of formula due to cow’s milk protein allergy, multiple food allergies, or of a number of gastrointestinal disorders.
This PurAmino formula will be distributed primarily to hospitals and other healthcare facilities to ensure access to this medically essential product for babies who need it.
The PurAmino will be transported to Reckitt’s facility in Zeeland, Michigan, “where it will be packaged and distributed through Mead Johnson’s existing distribution network.”
Reckitt said it is helping address the critical infant formula shortage in the United States by operating its plants 24 hours a day, seven days a week; seek authorization to import base powder from its Singapore plant and finance the transport of this powder; and working with its partners and retailers “to expedite orders and prioritize formulas in their fulfillment centers to fill shelves faster.”
Mead Johnson, which is owned by Reckitt, makes the Enfamil brand of infant formula.
Last week, the FDA announced that a hypoallergenic infant formula for cow’s milk protein allergy, Nestlé SMA Nutrition Althéra, is being imported from the Netherlands.
The FDA has been working for months with foreign manufacturers to import infant formula due to a critical shortage in the United States.
The shortage was partly triggered by a nationwide recall of infant formula produced at Abbott Nutrition’s facilities in Sturgis, Michigan, which were then closed for three months from February.
Abbott, one of the largest infant formula manufacturers in the United States, recalled Similac, Alimentum and EleCare powdered infant formula.
The recall left store shelves empty and retailers imposed limits on how much a person could buy. Supply had previously been tight due to supply chain issues during the COVID-19 pandemic.
Abbott in Michigan restarted on June 4 but closed two weeks later due to storm damage. The factory restarted at the beginning of July.